HIV-Protease Inhibitors Contribute to P-Glycoprotein Efflux Function Defect in Peripheral Blood Lymphocytes From HIV-Positive Patients Receiving HAART
- 1 August 2001
- journal article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 27 (4) , 321-330
- https://doi.org/10.1097/00042560-200108010-00001
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Significance of P-glycoprotein for the pharmacology and clinical use of HIV protease inhibitorsAIDS, 2000
- Molecular dissection of the human multidrug resistance P-glycoproteinBiochemistry and Cell Biology, 1999
- A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vesselsProceedings of the National Academy of Sciences, 1998
- A new, striking morphological alteration of P-glycoprotein expression in NK cells from AIDS patientsImmunology Letters, 1998
- Transmembrane P-Glycoprotein (P-gp/P-170) in HIV Infection: Analysis of Lymphocyte Surface Expression and Drug-Unrelated FunctionAIDS Research and Human Retroviruses, 1995
- Zidovudine Induces the Expression of Cellular Resistance Affecting Its Antiviral ActivityAIDS Research and Human Retroviruses, 1994
- Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype [see comments]Blood, 1992
- Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes [see comments]Blood, 1992
- Resistance of HIV-1 to AZT Might Also Involve the Cellular Expression of Multidrug Resistance P-GlycoproteinAIDS Research and Human Retroviruses, 1992
- Cross-resistance to anti-HIV nucleoside analogs in multidrug-resistant human cellsBiochemical and Biophysical Research Communications, 1990